Midwest Sees Decrease in Venture Capital Investment

Healthcare startup companies in the Midwest saw a decrease in venture capital this year, raising $507.8 million across 144 companies in the first six months of 2015. Cleveland and Minneapolis led funding for this region.
According to an article on MedCity News:

By contrast, nationwide biotech startups alone $7.8 billion for the first half of the year, according to Dow Jones. And this year’s Midwest investments are down from last year, when 139 startups raised $777.3 million.
This could stem from the fact that while biotech investment remains bullish, devicemakers are finding it harder to attract equity investment. And, of course, biopharma tends to concentrate on the coasts, whereas devices are often in the Heartland.
[…] Ohio companies led the way in terms of investment, bringing in $158.6 million. Minnesota came in next, with $100.5 million, followed by Wisconsin at $73.1 million.
Medical device companies raised the most equity – $227 million. This was followed by healthcare software and services, at $155 million, and biopharma at just $126 million.

Click here to read the full article on MedCity News.